Biotech · Private company
Clexio Biosciences Ltd.
Track this companyFree. Adds Clexio Biosciences Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CLE-100Phase 2 · Adjunctive Treatment of Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CLE-100Phase 2 · Adjunctive Treatment of Major Depressive Disorder (MDD)ClinicalTrials.gov · fetched Nov 12, 2026
- CLE-400Phase 2 · Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)ClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderPHASE2 · COMPLETED · started Mar 18, 2024ClinicalTrials.gov NCT06340958 · fetched Nov 12, 2026
- A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia ParestheticaPHASE2 · COMPLETED · started Jan 29, 2024ClinicalTrials.gov NCT06262607 · fetched Nov 12, 2026
- A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyPHASE2 · COMPLETED · started Sep 5, 2019ClinicalTrials.gov NCT04103892 · fetched Nov 12, 2026